AMN Healthcare Services, Inc.
NYSE:AMNMedical - Care Facilities
-$1.29 today
- Market cap
- $1.45B
- Beta
- 0.44
- P/E (TTM)
- -37.3
- EPS (TTM)
- -$0.83
Volume 0.55M
Average 1.02M
AMN Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
AMN Healthcare Services, Inc.NYSE: AMN
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $35.66M fell 10.5% year over year, behind the -9.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 4.2% from the prior quarter. Over 3 fiscal years it compounded at +4.5% a year.
Context
- Depreciation & amortization amounted to 5.7% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -10.5% toward the trailing-twelve-month pace of -9.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 156.6M USD
- Year-over-year change
- -9.9%
- 4-year CAGR
- +10.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 156.6M | -9.9% |
| FY2024 | 2024-12-31 | 173.78M | +8.0% |
| FY2023 | 2023-12-31 | 160.93M | +17.4% |
| FY2022 | 2022-12-31 | 137.11M | +32.2% |
| FY2021 | 2021-12-31 | 103.7M | — |
Depreciation & Amortization vs competitors
How AMN compares with its peers on the latest reported figures
- AMN's LTM Mar 2026 depreciation & amortization of $152.4M is the highest of the 11 companies compared; the peer median is $32.51M.
- Its year-over-year change of -9.9% is the 7th highest of 11, against a peer median of -0.7%.
- Depreciation & amortization amounts to 4.5% of revenue for AMN, versus a peer median of 7.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $152.4M | -9.9% | +4.5% | 4.5% | |
| LTM Mar 2026 | $118.75M | +4.1% | +8.7% | 6.3% | |
| LTM Mar 2026 | $89.29M | +36.3% | -1.5% | 63.2% | |
| LTM Jun 2026 | $56.96M | -3.2% | +16.6% | 27.3% | |
| LTM Mar 2026 | $51.8M | -13.5% | +0.6% | 6.2% | |
| LTM Mar 2026 | $44.09M | +5.8% | +4.6% | 14.1% | |
| LTM Mar 2026 | $20.93M | +5.3% | +16.1% | 2.4% | |
| LTM Mar 2026 | $12.56M | +1.9% | +16.6% | 8.3% | |
| LTM Mar 2026 | $7.53M | -25.6% | +10.8% | 7.3% | |
| LTM Dec 2025 | $3.61M | -34.2% | +9.0% | — | |
| LTM Mar 2026 | $179K | -14.4% | -13.2% | — | |
| Peer median (excluding AMN) | $32.51M | -0.7% | +8.9% | 7.8% | |
Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.98B | 5.24B | 3.79B | 2.98B | 2.73B |
| Cost of Revenue | 2.67B | 3.53B | 2.54B | 2.06B | 1.96B |
| Gross Profit | 1.31B | 1.72B | 1.25B | 919.38M | 774.06M |
| Gross Margin | 32.9% | 32.7% | 33.0% | 30.8% | 28.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 730.45M | 936.58M | 756.24M | 632.49M | 593.02M |
| Operating Expenses | 831.6M | 1.07B | 911.15M | 1.02B | 740.89M |
| Depreciation & Amortization | 103.7M | 137.11M | 160.93M | 173.78M | 156.6M |
| EBITDA | 581.7M | 784.21M | 499.36M | 71.11M | 101.13M |
| EBITDA Margin | 14.6% | 15.0% | 13.2% | 2.4% | 3.7% |
| Operating Income | 478M | 647.1M | 338.43M | (102.67M) | 33.17M |
| Operating Margin | 12.0% | 12.3% | 8.9% | -3.4% | 1.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 34.08M | 40.4M | 54.14M | 69.9M | 45.59M |
| Other Income / Expenses | (34.08M) | (40.4M) | (54.14M) | (69.9M) | (134.23M) |
| Income Before Tax | 443.92M | 606.7M | 284.29M | (172.57M) | (101.06M) |
| Pre-Tax Margin | 11.1% | 11.6% | 7.5% | -5.8% | -3.7% |
| Income Tax Expense | 116.53M | 162.65M | 73.61M | (25.6M) | (5.36M) |
| Net Income | 327.39M | 444.05M | 210.68M | (146.98M) | (95.7M) |
| Net Margin | 8.2% | 8.5% | 5.6% | -4.9% | -3.5% |
| EPS (Basic) | 6.87 | 9.96 | 5.38 | (3.85) | (2.48) |
| EPS (Diluted) | 6.81 | 9.90 | 5.36 | (3.85) | (2.48) |
| Weighted Avg Shares | 47.69M | 44.59M | 39.17M | 38.19M | 38.52M |
| Weighted Avg Shares (Diluted) | 48.05M | 44.87M | 39.34M | 38.19M | 38.52M |
AMN Healthcare Services, Inc.
NYSE:AMN
Intrinsic Alpha fair value
Locked
Current Price
$37.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.